SS

Suchi Saria

AI OG — Founder & CEO Bayesian Health, Endowed Chair/AI Prof Johns Hopkins, Seed Investor to 15+ AI Cos

New York, New York

Work Experience

  • Founding Board of Directors

    2024

  • Co-Founder

    2022

  • Young Global Leader (YGL)

    2018

    The World Economic Forum selects 100 leaders under 40 worldwide annually. I was selected in 2018.

  • Member of Global Futures Council on AI and Robotics

    2016 - 2018

  • NAM Emerging Leaders In Health and Medicine

    2018

    Each year, the National Academy of Medicine (elected group of the leading scientists and practitioners of their time) selects up to 10 early- and mid-career professionals with demonstrated leadership and exceptional professional achievement in biomedical science, population health, health care and related fields. I was selected in 2018. https://nam.edu/programs/emerging-leaders-forum/

  • CEO & Founder, Chief Scientific Officer

    2019

    Bayesian Health is on a mission to make healthcare proactive by empowering clinicians with real-time data to save lives. Build on research from leading academic medical centers, funded by top investors (eg Andreessen Horowitz, AMA, Catalio), Bayesian’s AI platform activates state-of-the-art AI within the electronic medical record (EMR) to deliver accurate and actionable clinical signals that catch life-threatening events early, resulting in better patient health outcomes.

  • Founding Director, Research and Technical Strategy, Malone Center for Enginering in Healthcare

    2017

  • Director, Machine Learning, AI & Healthcare Lab

    2013

  • John C. Malone Endowed Chair and Associate Professor (with Tenure)

    2018

  • Assistant Professor

    2012

  • Advisory Board

    2018

    Scripps Research Translational Institute Sanofi PatientPing — care coordination network to improve patient care through access to real-time visit data Child Health Imprints — Singapore based company leading data-driven transformation in neonatal care Halcyon Health — offering an integrated, evidence-based SUD treatment program focused on long-term care. Novartis, Cardiology Data Science Duality Tech — secure, privacy-preserving computing and machine learning for the enterprise

2022 - 2023

  • Investment Partner

    2022 - 2023

2014 - 2021

  • Technical Advisor and Seed Investor

    2014 - 2021

    PatientPing was acquired by Appriss Health: https://patientping.com/news/appriss-health-completes-acquisition-of-patientping/

2005 - 2011

  • Researcher PHD Student

    2005 - 2011

    With Daphne Koller. Machine Learning for time series and health informatics applications.

2008 - 2008

  • Research Intern

    2008 - 2008

    Internship with Eric Horvitz. Built novel computational techniques for traffic prediction